{"disease":{"id":"cystinosis","name":"Cystinosis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"cysteamine-hydrochloride","indication_name":"Corneal cystine crystal deposits in cystinosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CYSTEAMINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Cystine","drug_class":"Cystine-depleting agents","quality_score":44,"revenue":null,"mechanism":"Cysteamine depletes cystine by converting it to cysteine and cysteine-cysteamine mixed disulfides, reducing corneal cystine crystal accumulation."},{"drug_id":"mercaptamine","indication_name":"Cystinosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cystagon","generic_name":"Mercaptamine","company_name":"Mylan","drug_phase":"marketed","molecular_target":"","drug_class":"Cystine Depleting Agent","quality_score":55,"revenue":null,"mechanism":"Cystagon works by binding to cystine and forming a disulfide bond, effectively removing cystine from the body."},{"drug_id":"cystagon","indication_name":"Cystinosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cystagon","company_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06027385","title":"Genetic Newborn Screening for Cystinosis and Spinal Muscular Atrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":300000,"lead_sponsor_name":"Cystinose Stiftung","has_results":false},{"nct_id":"NCT05843851","title":"Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria","phase":"NA","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Cystinose Stiftung","has_results":false},{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT00359684","title":"Use of Cysteamine in the Treatment of Cystinosis","phase":"","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05959668","title":"Development of Health-related Quality of Life Instrument for Patients With Cystinosis","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Cystinose Stiftung","has_results":false},{"nct_id":"NCT00100204","title":"Salivary Proteins in Disease and Health","phase":"","overall_status":"COMPLETED","enrollment_count":264,"lead_sponsor_name":"National Institute of Dental and Craniofacial Research (NIDCR)","has_results":false},{"nct_id":"NCT01197378","title":"Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05146830","title":"A Long-Term Follow-Up Study of Participants With Cystinosis Who Previously Received CTNS-RD-04","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"Stephanie Cherqui","has_results":false},{"nct_id":"NCT03919981","title":"CYSTEA-BONE Clinical Study","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04246060","title":"Observational Study to Assess the Quality of Life in Nephropathic Cystinosis Patients","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":31,"lead_sponsor_name":"Chiesi SA/NV","has_results":false},{"nct_id":"NCT06910813","title":"DFT383 in Pediatric Participants With Nephropathic Cystinosis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05545774","title":"Neuromuscular Characterisation in Late Adolescent and Adult Cystinosis Patients","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT00071903","title":"The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study","phase":"","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT01744782","title":"Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT00074516","title":"Kidney Transplantation in Patients With Cystinosis","phase":"","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT04071548","title":"The Effect of Exercise on Muscle Dysfunction in Cystinosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT03897361","title":"Stem Cell Gene Therapy for Cystinosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT04125927","title":"Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"RECORDATI GROUP","has_results":false},{"nct_id":"NCT04069260","title":"A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Eloxx Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02124070","title":"Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}